Investigation of the effect of occult invasive cancer on progress towards successful cervical screening

Journal of Medical Screening

Volumn 5, Issue 2, 1998, Pages 92-98

  Herbert, Amanda ^a   Bryant, T N ^b   Campbell, M J ^b   Smith, Jenifer ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cervical cancer; Cohort effects; Incidence

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER SCREENING; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; RISK ASSESSMENT; UTERINE CERVIX CANCER;

EID: 0031813530     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.5.2.92     Document Type: Article

References (23)

1. Cancer Research Campaign. Cancer of the cervix uteri. London: CRC, 1994. (Factsheet No 12.)
2. Cancer Research Campaign. Cancer - world perspectives. London: CRC, 1995. (Factsheet No 22.)
3. Parkin DM, Nguyen-Dinh X, Day NE. The impact of screening on the incidence of cancer in England and Wales. Br J Obstet Gynaecol 1985;92:150-7.
4. Department of Health. Cervical cytology 1990-91 to 1994-95. Summary information from form KC53, England. London: Government Statistical Service, DH Statistics Division 2B, 1990-1995.
5. Herbert A, Stein K, Bryant TN, et al. Relation between the incidence of invasive cervical cancer and the screening interval: is a five year interval too long? J Med Screen 1996; 3:140-5.
6. Office for National Statistics. Population and health monitor 96/2. London: ONS, 1996.
7. Department of Health. Health of the nation. London: DOH, 1992.
8. Wolfendale MR, King S, Usherwood M McD. Abnormal cervical smears: are we in for an epidemic? BMJ 1983;287: 526-8.
9. Roberts A. Cervical cytology in England and Wales, 1965-80. Health Trends 1982;14:41-3.
10. Draper GJ, Cook GA. Changing patterns of cervical cancer rates. BMJ 1983;287:510-12.
11. Osmond C, Gardner MJ, Acheson ED, et al. Trends in cancer mortality 1951-1980. Analyses by period of birth and death. London: HMSO, 1988. (DH1, No 11.)
12. Beral V, Booth M. Predictions of cervical cancer incidence and mortality in England and Wales. Lancet 1986; i:495.
13. Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cancer. Br J Cancer 1996;73:1001-5.
14. Parkin DM, Day NE. Deaths from cervical cancer [letter]. Lancet 1986;i:797.
15. Herbert A. Cervical screening: effect of screening may be underestimated [letter]. BMJ 1997;314:1277.
16. Christopherson WM, Lundin FE Jr, Mendez WM, et al. Cervical cancer control: a study of the morbidity and mortality trends over a twenty-one year period. Cancer 1976;38:1357-66.
17. Johannesson G, Geirsson G, Day N. The effect of mass screening in Iceland, 1965-74, on the incidence and mortality of cervical carcinoma. Int J Cancer 1978;21:418-25.
18. Forrest P. Breast cancer screening. Report to the health ministers of England, Wales, Scotland and Northern Ireland. London: HMSO, 1986.
19. Herbert A, Breen C, Bryant TN, et al. Invasive cervical cancer in Southampton and South West Hampshire: effect of introducing a comprehensive screening programme. J Med Screen 1996;3:23-8.
20. Wessex Regional Health Authority. OPCS mid-year population estimates 1985-1995.
21. Shepherd JH. Cervical and vulva cancer: changes in FIGO definitions of staging. Br J Obstet Gynaecol 1996;103: 405-6.
22. Gustafsson L, Ponten J, Bergstrom, et al. International incidence rates of invasive cancer before cytological screening. Int J Cancer 1997;71:159-65.
23. Parkin DM. Screening for cervix cancer in developing countries. In: Miller AB, Chamberlain J, Day NE, et al, eds. Cancer screening. Cambridge: Cambridge University Press, 1991:185-98. (Published on behalf of the International Union Against Cancer.)